During the past decade, Clinical Insights conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Insights" #1 sponsor was "National Institute of Mental Health (NIMH)" with 4 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Cephalon" with 1 trials sponsored and "Cyberonics, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Insights" #1 collaborator was "Duke University" with 1 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator, "Otsuka America Pharmaceutical" with 1 trials as a collaborator and "University of North Carolina, Chapel Hill" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Insights" are "Schizophrenia" (8 trials), "Major Depressive Disorder" (4 trials), "Schizoaffective Disorder" (2 trials), "Alzheimer Disease" (1 trials) and "Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Clinical Insights" in a lesser frequency.

Most popular intervention types in "Clinical Insights" are "Drug" (15 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "ADT" (2 trials), "Aripiprazole" (2 trials), "Metformin" (2 trials) and "OPC-34712" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Insights" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Insights". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Clinical Insights, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Insights, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".